kanamycin a has been researched along with prednisolone in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (50.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gorodetskiĭ, MM; Stel'makh, VI | 1 |
| Ellorhaoui, M; Storch, W; Tauchnitz, C | 1 |
| Mori, S | 1 |
| Laibson, PR; Willis, WE | 1 |
| Hanazono, H; Imamura, M; Sakamoto, S | 1 |
| Taniai, S | 1 |
| Inagaki, M; Majima, Y; Mitsui, H; Miyoshi, Y; Sakakura, Y | 1 |
| Saito, H; Tsubokawa, T | 1 |
| KATSU, M; OSUGA, H; YASU, M | 1 |
| ABBOTT, J; RAINES, D; YARINGTON, CT | 1 |
| Akagawa, S; Hebisawa, A; Kawabe, Y; Kurashima, A; Machida, K; Masuda, K; Miyamoto, M; Nagai, H; Nagayama, N; Ohashi, R; Tamura, A; Tsuchiya, K; Yotsumoto, H | 1 |
| Chida, K; Fujita, K; Hayakawa, H; Nakamura, Y; Nakano, Y; Shirai, M; Suda, T | 1 |
1 review(s) available for kanamycin a and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for kanamycin a and prednisolone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Treatment of severe forms of meningococcal infection in adults].
Topics: Adolescent; Adult; Diuretics, Osmotic; Female; Heparin; Humans; Kanamycin; Male; Meningococcal Infections; Penicillins; Prednisolone; Vasoconstrictor Agents | 1976 |
[Chronic tuberculous meningitis in a case of known Mycobacterium kansasii infection].
Topics: Adult; Burns; Cell Count; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Lymphocytes; Male; Mycobacterium; Prednisolone; Pyrazinamide; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Uveitis | 1974 |
[Distribution of antibiotics in various parts of the body, with special reference to visceral organs and gonads].
Topics: Abscess; Amniotic Fluid; Animals; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Erythromycin; Female; Fetus; Genitalia, Female; Kanamycin; Kidney; Menstruation; Milk, Human; Penicillins; Placenta; Prednisolone; Pregnancy; Rats; Tetracycline; Trypsin; Uterus | 1971 |
Intractable Mycobacterium fortuitum corneal ulcer in man.
Topics: Accidents, Occupational; Anti-Bacterial Agents; Antitubercular Agents; Chronic Disease; Corneal Ulcer; Drug Resistance, Microbial; Eye Burns; Humans; Kanamycin; Keratitis; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Prednisolone; Species Specificity | 1971 |
Malignant histiocytosis: a case of generalized histiocytosis with infiltration of Langerhans' granule-containing histiocytes.
Topics: Antibiotics, Antineoplastic; Autopsy; Blood Cell Count; Child; Erythrocytes; Female; Histiocytes; Humans; Kanamycin; Leukocyte Count; Liver; Lymph Nodes; Lymphatic Diseases; Methotrexate; Microscopy, Electron; Prednisolone; Skin; Skin Manifestations | 1971 |
[Studies on the treatment of experimental chronic tuberculosis with steroid hormone as a stimulation therapy and the distribution of 14C-labeled isoniazid in the tuberculous mice].
Topics: Animals; Carbon Isotopes; Chronic Disease; Ethionamide; Female; Isoniazid; Kanamycin; Lung; Mice; Prednisolone; Tuberculosis, Pulmonary | 1967 |
Absorption of various drugs through the rabbit's respiratory mucosa in vitro.
Topics: Absorption; Animals; Cefazolin; Doxycycline; Immunoenzyme Techniques; Immunoglobulin G; Kanamycin; Mucous Membrane; Nasal Mucosa; Penicillin G; Pharmaceutical Preparations; Prednisolone; Rabbits; Respiratory System | 1983 |
[A study on maximal permissible drug concentration for transnasal medication from the viewpoint of ciliary activity of the cultured human paranasal mucosa].
Topics: Acetylcysteine; Administration, Intranasal; Cells, Cultured; Humans; Kanamycin; Maximum Allowable Concentration; Mucociliary Clearance; Nasal Mucosa; Paranasal Sinuses; Polyethylene Glycols; Prednisolone | 1994 |
[Current drug therapy].
Topics: Anti-Bacterial Agents; Colistin; Kanamycin; Penicillins; Prednisolone | 1963 |
WEGENER'S GRANULOMATOSIS.
Topics: Antifibrinolytic Agents; Autoimmune Diseases; Drug Therapy; Granulomatosis with Polyangiitis; Humans; Hydrocortisone; Kanamycin; Pathology; Prednisolone; Vitamin K | 1965 |
[Case of pulmonary mycobacterium avium complex disease, showing hypersensitivity pneumonitis-like diffuse shadow].
Topics: Alveolitis, Extrinsic Allergic; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Humans; Kanamycin; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prednisolone; Steam Bath; Treatment Outcome; Tuberculosis, Pulmonary; Water Microbiology | 2006 |
[A case of severe intestinal tuberculosis, treated with ciprofloxacin, kanamycin and prednisolone].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Kanamycin; Male; Prednisolone; Tuberculosis, Gastrointestinal | 2006 |